Downloads: 1 | Views: 144 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Research Paper | Medical Surgical | India | Volume 12 Issue 2, February 2023

Etiology and Clinical Manifestations of Mucormycosis during the COVID-19 Pandemic

Dr Niral Modi | Dr Ishita Shah | Dr Purnima

Abstract: Mucormycosis is an aggressive infection caused by the fungi of order Mucorales, class Zygomycetes. It is an angio-invasive fungus found freely in environment. Mucor infection is associated with impaired immune function; patients with uncontrolled diabetes, cancer, organ transplant recipients and those on immunosuppressants are vulnerable for developing mucormycosis. The incidence of mucormycosis India is estimated to be much higher than that of the developed countries as is, however, there has been an exponential rise in incidence of mucormycosis following the COVID-19 pandemic. The common feature among the affected patients was that they had a history of or active COVID-19 infection as well as high dose steroid administration. A combined medical and surgical approach was adapted for the treatment. Early diagnosis and aggressive treatment formed the mainstay of management.

Keywords: Mucormycosis, COVID-19, Amphotericin B, Modified Denker's approach

Edition: Volume 12 Issue 2, February 2023,

Pages: 1469 - 1476